BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 15611632)

  • 1. New advances in the DNA damage response network of Fanconi anemia and BRCA proteins. FAAP95 replaces BRCA2 as the true FANCB protein.
    Fei P; Yin J; Wang W
    Cell Cycle; 2005 Jan; 4(1):80-6. PubMed ID: 15611632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
    Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
    Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for subcomplexes in the Fanconi anemia pathway.
    Medhurst AL; Laghmani el H; Steltenpool J; Ferrer M; Fontaine C; de Groot J; Rooimans MA; Scheper RJ; Meetei AR; Wang W; Joenje H; de Winter JP
    Blood; 2006 Sep; 108(6):2072-80. PubMed ID: 16720839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC.
    Taniguchi T; D'Andrea AD
    Blood; 2002 Oct; 100(7):2457-62. PubMed ID: 12239156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNF4-mediated polyubiquitination regulates the Fanconi anemia/BRCA pathway.
    Xie J; Kim H; Moreau LA; Puhalla S; Garber J; Al Abo M; Takeda S; D'Andrea AD
    J Clin Invest; 2015 Apr; 125(4):1523-32. PubMed ID: 25751062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fanconi anemia complementation group FANCD2 protein serine 331 phosphorylation is important for fanconi anemia pathway function and BRCA2 interaction.
    Zhi G; Wilson JB; Chen X; Krause DS; Xiao Y; Jones NJ; Kupfer GM
    Cancer Res; 2009 Nov; 69(22):8775-83. PubMed ID: 19861535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
    Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
    Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathogenesis of fanconi anemia.
    Taniguchi T; Dandrea AD
    Int J Hematol; 2002 Feb; 75(2):123-8. PubMed ID: 11939257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway.
    van Twest S; Murphy VJ; Hodson C; Tan W; Swuec P; O'Rourke JJ; Heierhorst J; Crismani W; Deans AJ
    Mol Cell; 2017 Jan; 65(2):247-259. PubMed ID: 27986371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in cisplatinum sensitivity is not associated with Fanconi Anemia/BRCA pathway inactivation in head and neck squamous cell carcinoma cell lines.
    Snyder ER; Ricker JL; Chen Z; Waes CV
    Cancer Lett; 2007 Jan; 245(1-2):75-80. PubMed ID: 16466850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
    Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FANCD2, FANCJ and BRCA2 cooperate to promote replication fork recovery independently of the Fanconi Anemia core complex.
    Raghunandan M; Chaudhury I; Kelich SL; Hanenberg H; Sobeck A
    Cell Cycle; 2015; 14(3):342-53. PubMed ID: 25659033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of a FANCE Splice Isoform in Regard to DNA Repair.
    Bouffard F; Plourde K; BĂ©langer S; Ouellette G; Labrie Y; Durocher F
    J Mol Biol; 2015 Sep; 427(19):3056-73. PubMed ID: 26277624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Fanconi anemia pathway of genomic maintenance.
    Levitus M; Joenje H; de Winter JP
    Cell Oncol; 2006; 28(1-2):3-29. PubMed ID: 16675878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. siRNA depletion of BRCA1, but not BRCA2, causes increased genome instability in Fanconi anemia cells.
    Bruun D; Folias A; Akkari Y; Cox Y; Olson S; Moses R
    DNA Repair (Amst); 2003 Sep; 2(9):1007-13. PubMed ID: 12967657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2.
    Hussain S; Wilson JB; Blom E; Thompson LH; Sung P; Gordon SM; Kupfer GM; Joenje H; Mathew CG; Jones NJ
    DNA Repair (Amst); 2006 May; 5(5):629-40. PubMed ID: 16621732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New complexities for BRCA1 and BRCA2.
    Kerr P; Ashworth A
    Curr Biol; 2001 Aug; 11(16):R668-76. PubMed ID: 11525763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FANCC, FANCE, and FANCD2 form a ternary complex essential to the integrity of the Fanconi anemia DNA damage response pathway.
    Gordon SM; Alon N; Buchwald M
    J Biol Chem; 2005 Oct; 280(43):36118-25. PubMed ID: 16127171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway.
    Ling C; Ishiai M; Ali AM; Medhurst AL; Neveling K; Kalb R; Yan Z; Xue Y; Oostra AB; Auerbach AD; Hoatlin ME; Schindler D; Joenje H; de Winter JP; Takata M; Meetei AR; Wang W
    EMBO J; 2007 Apr; 26(8):2104-14. PubMed ID: 17396147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.